| NCT06533826 |
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd |
| NCT05721248 |
STOP-HER2: Stopping Trastuzumab in HER2+ MBC |
| NCT01042548 |
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum |
| NCT06590857 |
Trial of 225Ac-DOTATATE (RYZ101) in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. |
| NCT05952557 |
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) |
| NCT06932757 |
Adjuvant Quisinostat in High-Risk Uveal Melanoma |
| NCT03351348 |
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control |
| NCT04768426 |
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer |
| NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer |
| NCT03972657 |
A Trial to Find Out if REGN5678 is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors |
| NCT06399757 |
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors |
| NCT04523857 |
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer |
| NCT06557148 |
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer |
| NCT00899626 |
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples from Colorectal Cancer Patients |
| NCT05047926 |
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients |
| NCT04752826 |
BI-1808 As a Single Agent and with Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) |
| NCT05752448 |
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) |
| NCT06878248 |
A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer |
| NCT04991948 |
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer |
| NCT06068257 |
Tumor-Derived FGF19 |
| NCT06557057 |
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk |
| NCT06726148 |
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors |
| NCT04443348 |
Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) |
| NCT03767348 |
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab |
| NCT04590326 |
A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018 |
| NCT02595957 |
Genomic Services Research Program |
| NCT02910557 |
Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection |
| NCT05766748 |
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer |
| NCT05673148 |
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, the ERASur Study |
| NCT05877430 |
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer |
| NCT05538130 |
A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors |
| NCT06483048 |
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer |
| NCT06734130 |
Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer |
| NCT06385925 |
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation |
| NCT06710548 |
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors |
| NCT06297525 |
Study of STP938 in Advanced Solid Tumours |
| NCT05810025 |
FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments |
| NCT04052048 |
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer |
| NCT04941430 |
7T MRI Scan for the Early Detection of Melanoma Brain Metastases |
| NCT04606030 |
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) |
| NCT04360330 |
SABER Study for Selected Early Stage Breast Cancer |
| NCT06586957 |
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors |
| NCT03558048 |
The Effect of IBD Flares on Serum PSA |
| NCT05539430 |
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma |
| NCT04039230 |
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. |
| NCT05968157 |
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick |
| NCT05879926 |
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 |
| NCT05573126 |
Phase 1/2 Study to Evaluate Vosilasarm (EP0062) as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer |
| NCT06420726 |
Resistance Exercise and Creatine in Colorectal Cancer |
| NCT04545957 |
Jump: MR Simulation For Radiation Therapy Master Protocol |
| NCT05267626 |
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer |
| NCT05990426 |
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy |
| NCT06675357 |
Using FAPI PET/MRI to Evaluate Prostate Cancer |
| NCT05868226 |
PRE-I-SPY Phase I/Ib Oncology Platform Program |
| NCT02610426 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer |
| NCT05227326 |
AOH1996 for the Treatment of Refractory Solid Tumors |
| NCT06743126 |
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma |
| NCT06633926 |
Integrative Approaches for Cancer Survivorship (IACS3) |
| NCT03863457 |
[18F] F-GLN by PET/CT in Breast Cancer |
| NCT04196257 |
BP1001-A in Patients With Advanced or Recurrent Solid Tumors |
| NCT05948826 |
First in Human Study of TORL-3-600 in Participants With Advanced Cancer |
| NCT04872166 |
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer |
| NCT06721065 |
A Study of Language Interpretation Solutions for People With Breast Cancer |
| NCT06549465 |
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) |
| NCT06376565 |
Improving Colonoscopy Surveillance for Patients with High Risk Colon Polyps |
| NCT06268665 |
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy |
| NCT05691465 |
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells |
| NCT05931874 |
Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors |
| NCT03538665 |
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons |
| NCT03090165 |
Ribociclib and Bicalutamide in AR+ TNBC |
| NCT04812366 |
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer |
| NCT03048266 |
Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients |
| NCT04449874 |
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation |
| NCT06833866 |
Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer |
| NCT06090266 |
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents |
| NCT04297020 |
Brain Health in Breast Cancer Survivors |
| NCT05020574 |
Microbiome and Association With Implant Infections |
| NCT06253520 |
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer |
| NCT02918474 |
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer |
| NCT04959474 |
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer |
| NCT06610474 |
Evaluation of an Online Prostate Cancer Screening Decision Aid |
| NCT02207465 |
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer |
| NCT05111574 |
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery |
| NCT05799274 |
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer |
| NCT05929820 |
Impact of Protect Your Colon™ on CRC Screening |
| NCT05107674 |
A Study of NX-1607 in Adults With Advanced Malignancies |
| NCT04471974 |
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
| NCT02016248 |
Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer |
| NCT05799248 |
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management |
| NCT03659448 |
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer |
| NCT05053230 |
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer |
| NCT06065748 |
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) |
| NCT06402357 |
High Intensity Focused Ultrasound in Prostate Cancer |
| NCT06026657 |
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells with or Without Naxitamab (Danyelza) for the Treatment of Patients with Metastatic, GD2 Expressing, HER2 Negative Breast Cancer |
| NCT04616248 |
In Situ Immunomodulation with CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients W/ Unresectable and Metastatic Solid Tumors |
| NCT04678648 |
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies |
| NCT06249048 |
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab |
| NCT05391126 |
GENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care |
| NCT06307548 |
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer |
| NCT07030348 |
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study |
| NCT02749474 |
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes |
| NCT06297265 |
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery |
| NCT06744465 |
NearWave Optical Molecular Monitoring |
| NCT05585320 |
A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors |
| NCT06639074 |
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial |
| NCT05679674 |
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer |
| NCT05209074 |
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma |
| NCT04756765 |
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer |
| NCT05327465 |
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy |
| NCT03452774 |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry |
| NCT03572374 |
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job |
| NCT06295965 |
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study |
| NCT04503265 |
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies |
| NCT06904365 |
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women |
| NCT06393374 |
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) |
| NCT03995082 |
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey |
| NCT05669482 |
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer |
| NCT05693766 |
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort |
| NCT06799065 |
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer |
| NCT00756665 |
Prostate Active Surveillance Study |
| NCT05361174 |
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer |
| NCT05579366 |
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) |
| NCT05268666 |
A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors |
| NCT05800665 |
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer |
| NCT05289466 |
Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation. |
| NCT05825482 |
Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout® |
| NCT06660420 |
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel) |
| NCT05869682 |
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy |
| NCT06340620 |
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope |
| NCT04421820 |
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours |
| NCT05653882 |
A Study Evaluating AB248 Alone or in Combination with Pembrolizumab in Adult Patients with Solid Tumors |
| NCT06202820 |
CV CARE: CardioVascular Care in PC Patients |
| NCT04998682 |
Prospective Evaluation of Targeted Axillary Dissection (TAD) |
| NCT06339827 |
ASk Questions in GYnecologic Oncology (ASQ-GYO) |
| NCT06399276 |
4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity |
| NCT06312176 |
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) |
| NCT06508827 |
Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma |
| NCT01638676 |
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients |
| NCT05054296 |
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring |
| NCT04022616 |
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients |
| NCT05989724 |
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors |
| NCT05463796 |
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer |
| NCT05838716 |
High-Dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients |
| NCT04975516 |
Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer |
| NCT05136196 |
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study |
| NCT04251416 |
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma |
| NCT04677816 |
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients |
| NCT06298916 |
64Cu-LNTH-1363S in Patients with Sarcoma or Gastrointestinal Tract Cancer |
| NCT05637216 |
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients |
| NCT05786924 |
A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers |
| NCT06205316 |
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma |
| NCT06566716 |
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass |
| NCT06246916 |
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) |
| NCT04914663 |
All-extremity Exercise During Breast Cancer Chemotherapy |
| NCT05840263 |
Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer |
| NCT04188535 |
Serial MRI Scans During Radiation Therapy |
| NCT05754658 |
African Cancer Genome: GMD |
| NCT04792463 |
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome |
| NCT05524935 |
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma |
| NCT06250335 |
Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients |
| NCT06617858 |
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment |
| NCT04115163 |
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer |
| NCT06662435 |
GYNecologic Cancer-Related COGnitive Impairment |
| NCT06774963 |
A Phase 1 Study of LNCB74 in Advanced Solid Tumors |
| NCT04969835 |
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours |
| NCT04331535 |
The Genomic Medicine at VA Study |
| NCT06500858 |
MBC Physical Activity Study |
| NCT06287463 |
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway |
| NCT05850663 |
Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer |
| NCT05998135 |
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer |
| NCT04887935 |
Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer |
| NCT06551116 |
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer |
| NCT05646316 |
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer |
| NCT06542835 |
Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity |
| NCT06568016 |
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers |
| NCT05981716 |
Young Breast Cancer Survivors Study |
| NCT06113016 |
Prevention of Frailty with Fisetin and Exercise (PROFFi) in Breast Cancer Survivors |
| NCT05384496 |
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma |
| NCT04751396 |
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors |
| NCT04997096 |
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy |
| NCT05125016 |
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer |
| NCT03990896 |
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial |
| NCT06555796 |
Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer |
| NCT03943316 |
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies |
| NCT06428396 |
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) |
| NCT05896839 |
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer |
| NCT05496686 |
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma |
| NCT05225363 |
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer |
| NCT05384535 |
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort |
| NCT06797635 |
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) |
| NCT04847063 |
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies |
| NCT05610735 |
Combination Therapy for Recurrent Ovarian Cancer |
| NCT04799535 |
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring |
| NCT06691035 |
Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer |
| NCT06192758 |
Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device |
| NCT06461416 |
A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework |
| NCT03354416 |
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer |
| NCT06551324 |
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). |
| NCT05980416 |
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 |
| NCT05590624 |
Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer |
| NCT03175224 |
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors |
| NCT05914116 |
A Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors |
| NCT05013216 |
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer |
| NCT03492424 |
Ablative Therapy in the Management of Prostate Cancer |
| NCT06704724 |
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. |
| NCT06291324 |
WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment |
| NCT06974734 |
A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies |
| NCT06757634 |
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) |
| NCT06639724 |
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer |
| NCT05692024 |
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER |
| NCT05305924 |
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer |
| NCT04130516 |
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and with Pembrolizumab |
| NCT06312124 |
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer |
| NCT02830724 |
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers |
| NCT05776524 |
Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer |
| NCT06492616 |
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence |
| NCT03686124 |
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors |
| NCT05268224 |
A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue |
| NCT06584396 |
Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study |
| NCT03819296 |
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer |
| NCT05036096 |
Cone Beam Breast CT for Breast Cancer Screening |
| NCT04568616 |
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) |
| NCT05232916 |
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects |
| NCT04457596 |
T-DM1 and Tucatinib Compared with T-DM1 Alone in Preventing Relapses in People with High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial |
| NCT05576896 |
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory |
| NCT05864196 |
Two Fraction Prostate SBRT With DIL SIB |
| NCT06326216 |
Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer |
| NCT06703996 |
InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors |
| NCT05692596 |
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics |
| NCT05716516 |
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER) |
| NCT04961996 |
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) |
| NCT05462496 |
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer |
| NCT00034216 |
Collection of Blood From Patients With Cancer |
| NCT06084416 |
A Study of Sovilnesib in Subjects with Ovarian Cancer |
| NCT04275557 |
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas |
| NCT06324357 |
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread |
| NCT02871726 |
Transrectal Ultrasound Robot-Assisted Prostate Biopsy |
| NCT06425926 |
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors |
| NCT06130826 |
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer |
| NCT05842057 |
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy |
| NCT05056857 |
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen |
| NCT00830557 |
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders |
| NCT06275126 |
Optimizing Surgical Decisions in Young Adults With Breast Cancer |
| NCT03745326 |
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients |
| NCT06518057 |
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer |
| NCT06542757 |
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy |
| NCT05036226 |
COAST Therapy in Advanced Solid Tumors and Prostate Cancer |
| NCT06465966 |
UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning |
| NCT06817226 |
BREAST Choice Decision Tool R21 |
| NCT04904757 |
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening |
| NCT04329065 |
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer |
| NCT05696626 |
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation |
| NCT06122896 |
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals |
| NCT06623396 |
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer |
| NCT05548296 |
A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma |
| NCT06364696 |
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors |
| NCT05930496 |
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors |
| NCT05377996 |
A Study of XMT-1660 in Participants With Solid Tumors |
| NCT02743858 |
Lymphedema Surveillance Study |
| NCT05830058 |
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma |
| NCT04858334 |
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation |
| NCT06582017 |
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma |
| NCT04305834 |
Abemaciclib and Endocrine Therapy in Older Patients with Breast Cancer. |
| NCT04825834 |
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) |
| NCT05607017 |
Losartan in Prevention of Radiation-Induced Heart Failure |
| NCT04114136 |
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies |
| NCT04567706 |
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma |
| NCT04115306 |
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer |
| NCT04816006 |
Breast Cancer, Reasoning, and Activity Intervention |
| NCT05754749 |
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions |
| NCT05245006 |
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer |
| NCT03096418 |
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response |
| NCT06105918 |
Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients with Biochemically Recurrent Prostate Cancer |
| NCT04462406 |
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial |
| NCT06216249 |
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) |
| NCT04557449 |
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors |
| NCT06355336 |
Real World Prostate Cancer Registry |
| NCT04270149 |
Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer |
| NCT06195306 |
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction |
| NCT06105749 |
Biennial CEM in Women with a Personal History of Breast Cancer |
| NCT06858449 |
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer |
| NCT03340506 |
Dabrafenib and/or Trametinib Rollover Study |
| NCT05913713 |
HIIT Following Breast Cancer Chemotherapy |
| NCT04349436 |
A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies |
| NCT05977036 |
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer |
| NCT05168618 |
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial |
| NCT06904313 |
Ultralow Dose PET Imaging for PSMA Expression |
| NCT06800313 |
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) |
| NCT05141513 |
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma |
| NCT03474913 |
Upright MRI for Prostate Cancer Screening |
| NCT04071236 |
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy |
| NCT05805436 |
Preop Laxatives in Robotic Urologic Surgery |
| NCT06534918 |
Precise Oncology Interventions in Nutrition and Training (OnPoint) |
| NCT06303713 |
LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer |
| NCT04371913 |
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study |
| NCT06288113 |
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial |
| NCT06112613 |
Mobile Health for Adherence in Breast Cancer Patients |
| NCT06111313 |
The University of Miami Adapt (UAdapt) Trial |
| NCT06515613 |
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors |
| NCT04890613 |
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation |
| NCT05946213 |
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer |
| NCT05223036 |
Testing Obeticholic Acid for Familial Adenomatous Polyposis |
| NCT06619236 |
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer |
| NCT05879913 |
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT |
| NCT04485013 |
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers |
| NCT03785249 |
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 |
| NCT02598349 |
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas |
| NCT03968406 |
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers |
| NCT06880549 |
A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors |
| NCT02600949 |
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer |
| NCT05341349 |
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-100M for the Treatment of Melanoma Brain Metastases |
| NCT05193149 |
Inspiratory Muscle Training in Obese Breast Cancer Survivors |
| NCT06052306 |
A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) |
| NCT06855706 |
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study |
| NCT04055649 |
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer |
| NCT04333706 |
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER) |
| NCT05743049 |
Collection of Circulating Biomarkers in Pancreatic Cancer |
| NCT05590949 |
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors |
| NCT06637306 |
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer |
| NCT06961006 |
A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012) |
| NCT05141149 |
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer |
| NCT07020806 |
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC) |
| NCT05794906 |
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies |
| NCT06600906 |
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer |
| NCT06006299 |
Investigating the Use of TaVNS to Treat Insomnia in Individuals with Breast Cancer (taVNS-insomnia-BC) |
| NCT06450106 |
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy |
| NCT06829199 |
A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003) |
| NCT06228599 |
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence |
| NCT05595499 |
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors |
| NCT06785636 |
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 |
| NCT06205849 |
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer |
| NCT06205836 |
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer |
| NCT05241249 |
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma |
| NCT04778449 |
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma |
| NCT06252649 |
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation |
| NCT05519449 |
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) |
| NCT06582849 |
Enhanced Assistance During Radiotherapy for Unmet Essential Needs |
| NCT01915225 |
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer |
| NCT06128525 |
Prostate Resection After Microwave Ablation (PRAMA) |
| NCT03678025 |
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer |
| NCT05128825 |
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
| NCT06129422 |
Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer |
| NCT06040125 |
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial |
| NCT00451022 |
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies |
| NCT06171269 |
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life |
| NCT05113368 |
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer |
| NCT06228768 |
Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer |
| NCT06099769 |
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer |
| NCT05892068 |
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain |
| NCT05498272 |
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations |
| NCT04739072 |
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study |
| NCT06027268 |
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer |
| NCT04657068 |
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors |
| NCT04167969 |
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer |
| NCT05334069 |
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection |
| NCT05789069 |
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors |
| NCT06246968 |
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer |
| NCT02332668 |
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) |
| NCT05712668 |
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors |
| NCT05868668 |
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain |
| NCT06182072 |
ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC) |
| NCT05352672 |
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma |
| NCT04365569 |
Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program |
| NCT05469269 |
Cleveland African American Prostate Cancer Project |
| NCT02526368 |
Pilot Study of (MR) Imaging with Pyruvate (13C) to Detect High Grade Prostate Cancer |
| NCT04729114 |
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer |
| NCT06792695 |
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer |
| NCT06524895 |
Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery |
| NCT06745895 |
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening |
| NCT05607095 |
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma |
| NCT05219695 |
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI) |
| NCT06067295 |
Longitudinal Advanced Prostate Cancer Cohort (LAPCC) |
| NCT05530655 |
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer |
| NCT05301114 |
Social Risk Factors and Discrimination in Cancer Survivorship |
| NCT05708950 |
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) |
| NCT04717050 |
Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity |
| NCT06016855 |
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors |
| NCT06782555 |
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab |
| NCT05471414 |
Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer |
| NCT06484595 |
Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials |
| NCT03854110 |
Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine |
| NCT05464810 |
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer |
| NCT06671912 |
Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial |
| NCT05245812 |
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy |
| NCT06677112 |
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer |
| NCT05043012 |
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study) |
| NCT04812912 |
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer |
| NCT05014295 |
Patient Recall of Cancer Screening and Diagnosis |
| NCT05739981 |
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
| NCT05659381 |
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer |
| NCT06516510 |
A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer |
| NCT05979610 |
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies |
| NCT05603910 |
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma |
| NCT02040610 |
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer |
| NCT06149481 |
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) |
| NCT06074510 |
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer |
| NCT04645810 |
A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence |
| NCT05241210 |
Real-Time Feedback (RTFB) to Improve Colonoscopy |
| NCT05365581 |
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer |
| NCT02170181 |
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation |
| NCT06075810 |
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer |
| NCT06055881 |
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy |
| NCT05827081 |
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer |
| NCT05691010 |
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer |
| NCT06585410 |
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma |
| NCT06749210 |
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY |
| NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors |
| NCT04175210 |
Prospective Randomized Study of Accelerated Radiation Therapy (PRART) |
| NCT06517212 |
Tirzepatide Weight Loss for MRD+ Early Breast Cancer |
| NCT04877912 |
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening |
| NCT06305312 |
Community Services Navigation to Advance Health Equity in Breast Cancer Screening |
| NCT06572410 |
Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision |
| NCT05138510 |
Sexual Health in Breast Cancer Patients |
| NCT06026410 |
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors |
| NCT05098210 |
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer |
| NCT05259410 |
Time Restricted Eating During Chemotherapy for Breast Cancer |
| NCT06536881 |
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming |
| NCT04098081 |
1911GCCC: Galeterone or Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma |
| NCT06412510 |
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT |
| NCT06369610 |
Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer |
| NCT06787612 |
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer |
| NCT04636710 |
Refining Local-Regional Therapy for IBC |
| NCT06989112 |
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer |
| NCT05366881 |
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease |
| NCT06072612 |
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. |
| NCT05655312 |
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma |
| NCT04291612 |
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease |
| NCT04905069 |
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy |
| NCT06362369 |
A Study of Oral 7HP349 (Alintegimod) in Combination with Ipilimumab Followed by Nivolumab Monotherapy |
| NCT06465368 |
A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause |
| NCT04644068 |
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies |
| NCT04687969 |
Multimodal Machine Learning Characterization of Solid Tumors |
| NCT04611568 |
War on Melanoma™ Public Health & Education Campaign |
| NCT05797168 |
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors |
| NCT06696768 |
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer |
| NCT06915168 |
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer |
| NCT05703269 |
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy |
| NCT06678269 |
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer |
| NCT06001268 |
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) |
| NCT05546268 |
Study of Oral MRT-2359 in Selected Cancer Patients |
| NCT03050268 |
Familial Investigations of Childhood Cancer Predisposition |
| NCT04891068 |
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer |
| NCT05838768 |
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. |
| NCT06500169 |
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors |
| NCT05755269 |
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women |
| NCT01102569 |
Pancreatic Cancer Genetics |
| NCT01492972 |
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer |
| NCT05132504 |
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer |
| NCT04668872 |
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation |
| NCT06244004 |
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial |
| NCT05964504 |
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) |
| NCT02333604 |
Cancer Experience Registry (CER) for Cancer Patients and Caregivers |
| NCT05094804 |
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents |
| NCT05691504 |
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers |
| NCT06086704 |
Study of 18F-FFNP Breast PET/MRI |
| NCT02977468 |
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer |
| NCT05490472 |
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors |
| NCT04265872 |
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC |
| NCT04829604 |
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) |
| NCT04044872 |
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity |
| NCT05924672 |
Efficacy of Ra-223 in PSMA PET Optimally Selected Patients |
| NCT05415072 |
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas |
| NCT05396872 |
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer |
| NCT03270072 |
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients |
| NCT05649072 |
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. |
| NCT06833268 |
Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan |
| NCT06408168 |
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial) |
| NCT06371768 |
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors |
| NCT06789172 |
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors |
| NCT05751668 |
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) |
| NCT06347068 |
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells |
| NCT04589468 |
Researching the Effect of Exercise on Cancer |
| NCT06103669 |
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) |
| NCT06817668 |
Evaluating Tolerability of ePUHRT With Brachytherapy Boost |
| NCT05563272 |
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors |
| NCT02863172 |
Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes |
| NCT06400472 |
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors |
| NCT04854304 |
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts |
| NCT06067269 |
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients with Prostate Cancer, HEATWAVE Trial |
| NCT05130801 |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
| NCT05736367 |
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer |
| NCT06643767 |
Evaluation of the Bexa Breast Examination |
| NCT05464667 |
Preoperative Irradiation for Stage I Breast Cancer |
| NCT06239467 |
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer |
| NCT05417867 |
Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer |
| NCT05355701 |
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. |
| NCT06697301 |
Safety and Efficacy of EIK1001-006 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. |
| NCT03228667 |
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors |
| NCT05039801 |
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors |
| NCT05795101 |
TRUDI: TDXD+Durva in HER2+/low IBC |
| NCT04580667 |
Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From Plasma |
| NCT03611868 |
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors |
| NCT06835569 |
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations |
| NCT05929768 |
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer |
| NCT06168812 |
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer |
| NCT03821246 |
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy |
| NCT06907446 |
Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies |
| NCT05318469 |
Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer |
| NCT03285412 |
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer |
| NCT06518746 |
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation |
| NCT05479812 |
Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors |
| NCT04754412 |
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study |
| NCT06818812 |
A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation |
| NCT01035112 |
Magnetic Resonance Imaging of Breast Cancer |
| NCT05155046 |
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy |
| NCT06070012 |
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma |
| NCT05369546 |
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis |
| NCT04989946 |
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer |
| NCT05396612 |
Role of the Immune Environment in Response to Therapy in Breast Cancer |
| NCT05654246 |
Susan G. Komen's ShareForCures |
| NCT06369246 |
PRORAD-5 PROstate RADiation in 5 Fractions: Phase Ib Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer |
| NCT05645380 |
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC |
| NCT03991962 |
Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma |
| NCT06651580 |
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study |
| NCT05704062 |
Quantitative MRI Assessment of Breast Cancer Therapy Response |
| NCT03065062 |
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors |
| NCT04684862 |
Infusion System for Hepatic Cancer |
| NCT06121180 |
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma |
| NCT05735080 |
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer |
| NCT05077280 |
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma |
| NCT04561362 |
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies |
| NCT04576104 |
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer |
| NCT03460769 |
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) |
| NCT06394804 |
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer |
| NCT06340646 |
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) |
| NCT06844669 |
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy |
| NCT05727904 |
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. |
| NCT06663072 |
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors |
| NCT06952504 |
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) |
| NCT05607004 |
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer |
| NCT04104776 |
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas |
| NCT00001276 |
Diagnosing and Treating Low Blood Sugar Levels |
| NCT06595160 |
Association of Plant-based Diet and Gut Microbiome Signature with Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma |
| NCT06764940 |
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients with Brain Metastases |
| NCT05242744 |
FTT PET/CT in Metastatic Prostate Cancer |
| NCT02701244 |
A Registry Study of Breast Microseed Treatment |
| NCT02584244 |
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers |
| NCT06229392 |
A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer |
| NCT05458544 |
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application |
| NCT06568692 |
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer |
| NCT04415944 |
Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy |
| NCT05535192 |
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients |
| NCT06614192 |
A Randomized Trial Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Over-Expressed Refractory Metastatic Colorectal Cancer |
| NCT06566092 |
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants |
| NCT04314401 |
National Cancer Institute "Cancer Moonshot Biobank" |
| NCT06129604 |
Pilot Window of Opportunity Trial (POET) |
| NCT00899301 |
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer |
| NCT01834001 |
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy |
| NCT05046301 |
Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications |
| NCT05112601 |
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma |
| NCT05058846 |
Pilot Study of Pancreatic Cancer Screening |
| NCT05396846 |
My Best GI Eating Study |
| NCT05839912 |
Excision of Lymph Node Trial (EXCILYNT) (Mel69) |
| NCT06444269 |
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial |
| NCT01365169 |
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" |
| NCT06215469 |
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) |
| NCT06042569 |
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial |
| NCT05373823 |
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors |
| NCT06392295 |
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer |
| NCT05435495 |
Mechanisms of Resistance to PSMA Radioligand Therapy |
| NCT05863195 |
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial |
| NCT05900895 |
Estradiol Plus Olaparib for Breast Cancer (PHOEBE) |
| NCT03699995 |
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma |
| NCT05629546 |
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors |
| NCT05080946 |
Using Aspirin to Improve Immunological Features of Ovarian Tumors |
| NCT02735746 |
Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis |
| NCT06746012 |
Designing a Dyad-Based MHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers |
| NCT06378346 |
GU-01: Glycyrrhizin in Prostate Cancer |
| NCT06503146 |
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection |
| NCT05049746 |
Identifying Decision Making Needs for Older Adult Women with Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy |
| NCT06882746 |
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas |
| NCT06325046 |
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer |
| NCT05534646 |
Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer |
| NCT05969860 |
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer |
| NCT05269160 |
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ) |
| NCT06750094 |
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy |
| NCT05417594 |
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies |
| NCT04134260 |
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial |
| NCT05627960 |
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies |
| NCT05604560 |
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer |
| NCT04009044 |
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast |
| NCT05059444 |
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation |
| NCT04879940 |
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization |
| NCT06083844 |
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy |
| NCT04968964 |
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing |
| NCT03842943 |
Neoadjuvant Combination Immunotherapy for Stage III Melanoma |
| NCT05826743 |
Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy |
| NCT05378464 |
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer |
| NCT06673095 |
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial |
| NCT05933395 |
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor |
| NCT05220046 |
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers |
| NCT06698146 |
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection |
| NCT04606446 |
Study of PF-07248144 in Advanced or Metastatic Solid Tumors |
| NCT06079346 |
A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer |
| NCT06112314 |
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) |
| NCT04379414 |
YES Study - Newly Diagnosed/Metastatic Intervention |
| NCT01851395 |
Rapid Autopsy and Procurement of Cancer Tissue |
| NCT05053555 |
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies |
| NCT05806814 |
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer |
| NCT05280314 |
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors |
| NCT05827614 |
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications |
| NCT03137095 |
Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI |
| NCT06409195 |
A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers |
| NCT05581004 |
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors |
| NCT03709446 |
Leflunomide in Previously Treated Metastatic Triple Negative Cancers |
| NCT06605404 |
Pan-tumor MRD Study |
| NCT06388304 |
THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence |
| NCT06376604 |
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies |
| NCT06745804 |
Study of 68Ga-R10602 |
| NCT06728072 |
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer |
| NCT04594772 |
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma |
| NCT02021604 |
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma |
| NCT04808427 |
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer |
| NCT04815876 |
PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2 |
| NCT05698576 |
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer |
| NCT05477576 |
Study of RYZ101 Compared with SOC in Pts W Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy |
| NCT04666727 |
Role of Diet on the Microbiome of the Digestive System |
| NCT04967976 |
Breast Mesh Used in Two-staged Breast Reconstruction |
| NCT05349227 |
Comprehensive Outcomes for After Cancer Health |
| NCT03861676 |
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT |
| NCT06172127 |
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer |
| NCT05983276 |
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer |
| NCT05721976 |
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study |
| NCT06023576 |
A Study of Blood Pressure Control During Cancer Treatment |
| NCT05272462 |
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer |
| NCT03704662 |
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma |
| NCT03971591 |
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors |
| NCT06635980 |
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer |
| NCT04258280 |
Improving Genetic Counseling for BRCA+ Mothers |
| NCT05629494 |
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test |
| NCT04329494 |
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer |
| NCT03073694 |
Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis |
| NCT05932862 |
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Patients With Advanced Solid Tumors |
| NCT05959291 |
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer |
| NCT04324294 |
Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions |
| NCT05910294 |
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer |
| NCT05608694 |
MRI Screening in Men at High Risk of Developing Prostate Cancer |
| NCT06447662 |
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. |
| NCT05150691 |
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors |
| NCT05535894 |
Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer |
| NCT05691491 |
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness |
| NCT06594991 |
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma |
| NCT04878094 |
A Study of Intra-operative Imaging in Women With Ovarian Cancer |
| NCT05316129 |
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer |
| NCT06708429 |
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System |
| NCT04631744 |
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) |
| NCT01050504 |
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer |
| NCT05864144 |
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors |
| NCT05056844 |
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge |
| NCT04282044 |
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies |
| NCT02870244 |
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes |
| NCT05912244 |
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma |
| NCT03909282 |
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma |
| NCT05040360 |
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors |
| NCT04886531 |
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers |
| NCT03161431 |
SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab |
| NCT05746182 |
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms |
| NCT06441474 |
Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women |
| NCT05933265 |
Study of LP-184 in Patients With Advanced Solid Tumors |
| NCT04339374 |
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer |
| NCT05305365 |
Study Assessing QBS72S For Treating Brain Metastases |
| NCT05156866 |
First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer |
| NCT06488365 |
In Vivo Liquid Biopsy of Melanoma (Cytophone) |
| NCT05961982 |
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study |
| NCT06568562 |
XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer |
| NCT05766891 |
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery |
| NCT06445062 |
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors |
| NCT05467891 |
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer |
| NCT06271291 |
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts |
| NCT06264180 |
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3) |
| NCT04748380 |
Shared Decision-making and Colorectal Cancer Screening |
| NCT05304962 |
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer |
| NCT06252662 |
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies |
| NCT04930991 |
High Dose Omeprazole in Patients With Pancreatic Cancer |
| NCT06524973 |
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers |
| NCT03562273 |
GammaPod Registry and Quality of Life Nomogram |
| NCT06727773 |
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer |
| NCT05034627 |
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer |
| NCT03746431 |
A Phase 1/2 Study of [225Ac]-FPI-1434 Injection |
| NCT06081127 |
Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function |
| NCT02064673 |
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy |
| NCT04471727 |
A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001) |
| NCT06318273 |
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer |
| NCT06593431 |
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial |
| NCT06620627 |
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection |
| NCT04569773 |
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer |
| NCT06646627 |
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors |
| NCT05856773 |
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy |
| NCT04175431 |
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study |
| NCT06545331 |
Study of XB010 in Subjects With Solid Tumors |
| NCT05903131 |
A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia |
| NCT07023731 |
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation |
| NCT05806931 |
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer |
| NCT04406831 |
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer |
| NCT05675059 |
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients |
| NCT02674100 |
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry |
| NCT04802759 |
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer |
| NCT04597359 |
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring |
| NCT06679400 |
Effects of Myofascial Massage and Patient-therapist Communication Levels on Shoulder Muscle Properties in Breast Cancer Survivors With Myofascial Pain |
| NCT06572800 |
Tka Assay for CDK4/6i |
| NCT04137900 |
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies |
| NCT05942300 |
CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer |
| NCT05523700 |
Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2) |
| NCT05291507 |
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System |
| NCT05960188 |
Project 1: Self-Triage by 2D Full-field Digital Mammography or Synthetic Images |
| NCT05663788 |
Web-based Learning Module on Optical Diagnosis of Early Colorectal Cancer |
| NCT04030507 |
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer |
| NCT04563507 |
Combined Immunotherapies in Metastatic ER+ Breast Cancer |
| NCT05723107 |
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) |
| NCT06464107 |
Endometrial Cell Collection With the PadKit |
| NCT06819007 |
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) |
| NCT06318507 |
The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy |
| NCT05996107 |
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, Node Positive, HR+/HER2- Breast Cancer |
| NCT05011188 |
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer |
| NCT06123988 |
Prolonged Overnight Fasting And/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer |
| NCT05784688 |
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors |
| NCT06322888 |
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D) |
| NCT06072807 |
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer |
| NCT05123807 |
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) |
| NCT05756907 |
Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer |
| NCT06638307 |
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer |
| NCT05295407 |
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy |
| NCT05226507 |
A Phase 1 Clinical Study of NXP800 in Subjects with Advanced Cancers and Expansion in Subjects with Ovarian Cancer |
| NCT05812807 |
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab |
| NCT05428007 |
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma |
| NCT04837209 |
Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer |
| NCT06710756 |
Lead-212 PSV359 Therapy for Patients With Solid Tumors |
| NCT04893109 |
ATEMPT 2.0: Adjuvant T-DM1 vs TH |
| NCT05997056 |
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors |
| NCT06428409 |
A Clinical Study of MK-2870 Alone or With Chemotherapy to Treat Gastrointestinal Cancers (MK-9999-02A) |
| NCT05323409 |
Improving Comprehensive Care of Cancer Patients |
| NCT04482309 |
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors |
| NCT00843375 |
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas |
| NCT04020575 |
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) |
| NCT06559059 |
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs |
| NCT05694559 |
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics |
| NCT05394259 |
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer |
| NCT06015659 |
ZN-c3 + Gemcitabine in Pancreatic Cancer |
| NCT06295159 |
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma |
| NCT04464759 |
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma |
| NCT05394675 |
A Study of DS-9606a in Patients With Advanced Solid Tumors |
| NCT06036875 |
CARE: Cancer Risk Perception and Women of Color |
| NCT04692675 |
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer |
| NCT05467670 |
Safety and Efficacy of Anti-CD47, ALX148 in Combination with Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer |
| NCT05804370 |
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) |
| NCT05938270 |
A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer. |
| NCT04150042 |
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells |
| NCT05169970 |
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer |
| NCT06040970 |
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer |
| NCT03025256 |
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease |
| NCT04300556 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types |
| NCT03093909 |
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases |
| NCT02997709 |
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients |
| NCT06760507 |
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics |
| NCT06598007 |
A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors |
| NCT04484909 |
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer |
| NCT05887609 |
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib |
| NCT05415709 |
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer |
| NCT06171607 |
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses |
| NCT04973007 |
Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases |
| NCT06139107 |
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole |
| NCT05941507 |
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors |
| NCT06134375 |
A Study of Tetrathiomolybdate (TM) Plus Capecitabine |
| NCT04983875 |
Mammography and Breast Arterial Calcification: an Information-Sharing Trial |
| NCT06625775 |
Dose Escalation and Expansion of BBO-10203 in Advanced Solid Tumors (BREAKER-101) |
| NCT04379570 |
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy |
| NCT04189770 |
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners |
| NCT05038332 |
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT]) |
| NCT00040352 |
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma |
| NCT05654532 |
Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer |
| NCT06756932 |
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer |
| NCT06654037 |
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer |
| NCT03851237 |
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy |
| NCT06925737 |
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) |
| NCT06699836 |
A Phase 2 Study of Leronlimab in Combination With TAS-102 + Bevacizumab in Previously Treated Participants With mCRC |
| NCT05035836 |
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) |
| NCT05034536 |
PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma |
| NCT05241236 |
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer |
| NCT06106282 |
Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) |
| NCT05115474 |
Study of Screening Brain MRIs in Stage IV Breast Cancer |
| NCT06217874 |
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer |
| NCT06437574 |
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer |
| NCT05485974 |
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation |
| NCT06926920 |
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer |
| NCT04796220 |
Focused Ultrasound and Gemcitabine in Breast Cancer |
| NCT04567420 |
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE) |
| NCT05568420 |
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC) |
| NCT06100874 |
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) |
| NCT05458674 |
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC |
| NCT05902520 |
Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors |
| NCT05958082 |
Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients with High-Risk Prostate Cancer |
| NCT05994482 |
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study |
| NCT05313191 |
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors |
| NCT06396091 |
A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer |
| NCT04588662 |
A Prospective Natural History Study in Uveal Melanoma |
| NCT06315491 |
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer |
| NCT06276491 |
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors |
| NCT06056791 |
Study of INKmune in Patients With mCRPC (CaRe Prostate) |
| NCT06173362 |
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer |
| NCT06411691 |
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer |
| NCT05593094 |
A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors |
| NCT00991094 |
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy |
| NCT05562791 |
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer |
| NCT06922591 |
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients |
| NCT06120491 |
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents |
| NCT05613894 |
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer |
| NCT04473794 |
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts |
| NCT06428682 |
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction |
| NCT06146920 |
Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation |
| NCT06625320 |
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) |
| NCT05563220 |
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer |
| NCT05764720 |
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach |
| NCT04771520 |
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors |
| NCT06671782 |
A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical Prostatectomy |
| NCT02361320 |
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer |
| NCT05941520 |
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer |
| NCT06636682 |
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer |
| NCT06188520 |
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors |
| NCT05470920 |
Genetic Testing Decision Aid |
| NCT05634720 |
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer |
| NCT04074720 |
Prospective Breast Cancer Biospecimen Collection |
| NCT05484973 |
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss |
| NCT04294927 |
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention |
| NCT05812027 |
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors |
| NCT05556473 |
F-Tryptophan PET/CT in Human Cancers |
| NCT06294873 |
Stool Sample Collection Study |
| NCT06608927 |
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma |
| NCT05546827 |
PRISAM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Melanoma |
| NCT04157127 |
Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma |
| NCT06471673 |
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer |
| NCT02861573 |
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) |
| NCT06780176 |
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida |
| NCT06179160 |
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation |
| NCT05092373 |
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax |
| NCT04573231 |
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer |
| NCT06402331 |
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
| NCT05770531 |
Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy |
| NCT06450873 |
Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery |
| NCT05611931 |
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma |
| NCT05797831 |
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer |
| NCT05319873 |
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer |
| NCT05497531 |
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers |
| NCT05912231 |
Ultrahypofractionation and Normal Tissue Toxicity |
| NCT03127631 |
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients |
| NCT04903873 |
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors |
| NCT05006131 |
Pancreatic Cancer Screening for At-risk Individuals |
| NCT05123482 |
A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies |
| NCT06545682 |
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) |
| NCT05803382 |
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers |
| NCT01530373 |
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients |
| NCT06270082 |
Study of IK-595 in RAS- or RAF-altered Advanced Tumors |
| NCT05206331 |
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study |
| NCT06073431 |
An Observational Research Study to Uncover Subtypes of Cancer Cachexia |
| NCT03866382 |
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors |
| NCT05464082 |
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC |
| NCT02451982 |
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas |
| NCT05665660 |
Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening |
| NCT04709276 |
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer |
| NCT03495427 |
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores |
| NCT05586360 |
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer |
| NCT05965180 |
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe |
| NCT05633160 |
64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) |
| NCT02400060 |
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients with Breast Cancer |
| NCT03876860 |
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis |
| NCT04701476 |
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC |
| NCT04394676 |
The Impact of Low Pressure Pneumo in RARP II |
| NCT04697576 |
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma |
| NCT04824027 |
Breast Elasticity Imaging During Neoadjuvant Chemotherapy |
| NCT03485794 |
Collection of Blood in Studying Metabolites in Patients With Prostate Cancer |
| NCT00539162 |
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women |
| NCT06253494 |
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer |
| NCT04839991 |
Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours. |
| NCT05483491 |
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer |
| NCT05411094 |
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer |
| NCT04614194 |
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib |
| NCT06239194 |
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors |
| NCT06686394 |
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009) |
| NCT06638294 |
Study in Patients With Breast Cancer Leptomeningeal Metastasis |
| NCT05478694 |
Outcomes of Focal Ablation for Prostate Cancer |
| NCT04147494 |
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues |
| NCT04550494 |
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations |
| NCT05000294 |
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types |
| NCT05076760 |
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors |
| NCT05408260 |
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer |
| NCT05020860 |
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer |
| NCT04754191 |
Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer |
| NCT05422794 |
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer |
| NCT06413680 |
A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies |
| NCT06906562 |
A Phase II Nationwide, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreas Cancer With FGFR Genetic Alterations |
| NCT05754580 |
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer |
| NCT05208762 |
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors |
| NCT06767462 |
An Ophthalmic Safety Study in Patients With Breast Cancer |
| NCT06130280 |
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer |
| NCT05824975 |
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) |
| NCT06369259 |
Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer |
| NCT05877859 |
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab |
| NCT06613100 |
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer |
| NCT04030559 |
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects |
| NCT06807359 |
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System |
| NCT05765500 |
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life |
| NCT06690775 |
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. |
| NCT05733000 |
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors |
| NCT05429970 |
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) |
| NCT05195970 |
Walnuts and Colon Health |
| NCT02757859 |
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery |
| NCT04586959 |
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer |
| NCT06374459 |
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis |
| NCT06223659 |
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers |
| NCT05672459 |
A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors |
| NCT06064149 |
The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study |
| NCT06395506 |
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation |
| NCT05877599 |
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation |
| NCT06006806 |
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy |
| NCT05029999 |
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer |
| NCT05898399 |
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients |
| NCT06115499 |
The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer |
| NCT04221542 |
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer |
| NCT06581406 |
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma |
| NCT05382442 |
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer |
| NCT05508906 |
Phase 1b Combo w/ Ribociclib, Alpelisib, or Everolimus |
| NCT04787042 |
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 |
| NCT06203106 |
NYSCF Scientific Discovery Biobank |
| NCT07029399 |
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors |
| NCT04598009 |
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma |
| NCT04230109 |
Sacituzumab Govitecan In TNBC |
| NCT06821009 |
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening |
| NCT04990609 |
EUS-RFA PANCARDINAL-1 Trial |
| NCT06191185 |
IMProving Adherence to Colonoscopy Through Teams and Technology |
| NCT05560685 |
SMART-ER: Symptom Monitoring With Patient-reported Outcomes |
| NCT06369285 |
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer |
| NCT03941756 |
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma |
| NCT04895709 |
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors |
| NCT06804785 |
Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS) |
| NCT04650256 |
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences |
| NCT06411756 |
Physical Activity Centers Empowerment |
| NCT06991556 |
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
| NCT04603209 |
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer |
| NCT04858009 |
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis |
| NCT04913285 |
A Study to Evaluate KIN-2787 in Participants with BRAF And/or NRAS Mutation Positive Solid Tumors |
| NCT05081609 |
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies |
| NCT06361056 |
Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials |
| NCT05036109 |
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease |
| NCT05243056 |
A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment |
| NCT03932409 |
Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer |
| NCT06271356 |
Breast Cancer - Navigate - Prospective Cohort |
| NCT06689956 |
Outcomes of Low-Risk Endometrial Cancer with Isolated Tumor Cells in the Sentinel Lymph Nodes: a Prospective, Multicenter, Cohort Study |
| NCT04397185 |
Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer |
| NCT06268015 |
Botensilimab and Balstilimab Optimization in Colorectal Cancer |
| NCT06576115 |
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer |
| NCT04157985 |
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors |
| NCT06553885 |
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC |
| NCT06147037 |
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours |
| NCT04929015 |
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study) |
| NCT03604315 |
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF |
| NCT00368615 |
Characterization of the Melanoma-Specific Immune Response |
| NCT06586515 |
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors |
| NCT06945315 |
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS) |
| NCT06230185 |
CtDNA Based MRD Testing for NAC Monitoring in TNBC |
| NCT05737615 |
PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 |
| NCT06444815 |
A Study of VET3-TGI in Patients With Solid Tumors |
| NCT05379985 |
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS |
| NCT03947385 |
Study of IDE196 in Patients with Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions |
| NCT06580015 |
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer |
| NCT05903885 |
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans |
| NCT06487507 |
Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS) |
| NCT06585488 |
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification |
| NCT05190978 |
Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction |
| NCT06604078 |
Breast Cancer AI Imaging Study |
| NCT05687188 |
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations |
| NCT04048278 |
Lidocaine Infusion in Pancreatic Cancer |
| NCT05597878 |
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy |
| NCT06888388 |
Long-term Safety of Nipple Sparing Mastectomy in Women With GPV in Breast Cancer |
| NCT06269978 |
Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients with Peritoneal Metastases from Colorectal Cancer |
| NCT06019988 |
Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer |
| NCT05542407 |
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer |
| NCT05984888 |
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer |
| NCT05722288 |
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers |
| NCT05445778 |
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer |
| NCT05960578 |
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study |
| NCT04486378 |
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients with CtDNA-positive, Resected Stage II (high Risk) and Stage III Colorectal Cancer |
| NCT03250078 |
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals |
| NCT05515978 |
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients |
| NCT04656678 |
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer |
| NCT06563388 |
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial |
| NCT05454488 |
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer |
| NCT04923178 |
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies |
| NCT05052671 |
ctDNA Assay in Patients With Resectable Pancreatic Cancer |
| NCT04777071 |
An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer |
| NCT03936478 |
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer |
| NCT06171178 |
A Study of ASP1012 in Adults With Solid Tumors |
| NCT02339571 |
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma |
| NCT04557956 |
Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment |
| NCT03694756 |
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer |
| NCT04969315 |
TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors |
| NCT06764485 |
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer |
| NCT03740256 |
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors |
| NCT03809585 |
Observational Study of Iris Tumors |
| NCT06496256 |
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial |
| NCT01102556 |
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease |
| NCT05806515 |
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation |
